Alteration of B cell function by Epstein-Barr virus

Published: May 29, 2009
Abstract Views: 447
PDF: 477
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Epstein-Barr virus (EBV) is a DNA virus belonging to the g-herpes virus family. Over 90% of the human population worldwide is infected by the virus. Primary infection usually takes place during childhood and is mostly asymptomatic. However, when primary infection is delayed, frequently a self-limiting disease develops, called infectious mononucleosis (IM). During IM, a massive expansion of virus-harbouring cells is observed. These cells are then mostly eliminated by a strong cytotoxic T cell response. The cellular target of the virus and its reservoir during lifelong persistence are B lymphocytes, in which the viral genome is present as a circular episome. In healthy individuals, a stable balance is established between the expansion of virus-infected B cells and their elimination by cytotoxic T cells. However, EBV also plays a role in the pathogenesis of several human lymphomas. In vitro, EBV-infected B cells give rise to stable transformed cell lines, designated lymphoblastoid cell lines (LCL).

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Supporting Agencies

How to Cite

Küppers, R. (2009). Alteration of B cell function by Epstein-Barr virus. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.247